CHANGING IMAGE OF TKIS: ORIGINAL, BIOSIMILAR AND GENERIC OPTIONS
BCR-ABL is a 210 kDa protein that is required for the proliferation of CML-specific myeloid cells and has sustained kinase activity. Kinase activity provides uncontrolled signal transduction related to cell proliferation, apoptosis and adhesion. Although there are many tyrosine kinase enzymes, imati...
Saved in:
| Main Author: | Cenk Sunu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924029559 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Options to optimize the access to biosimilars: analysis and solutions
by: O. V. Kirsanova, et al.
Published: (2018-05-01) -
INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW
by: D. G. Tolkacheva, et al.
Published: (2018-02-01) -
INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW
by: D. G. Tolkacheva, et al.
Published: (2018-02-01) -
Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available
by: F. V. Gorkavenko, et al.
Published: (2019-07-01) -
Highly effective treatment options for rheumatoid arthritis afforded by the availability of biosimilars
by: Leticia A. Shea, et al.
Published: (2025-03-01)